Boston Scientific Vercise PC Manual

Vercise™ PC
Information for
Prescribers
en tres rufr arde elit cznl sksv plhuno da pt ptBR
Directions for Use
Instrucciones de uso
Mode d’emploi
Gebrauchsanweisung
Istruzioni per l’uso
Gebruiksaanwijzing
Bruksanvisning
Käyttöohje
Bruksanvisning
Brugsanvisning
Instruções de Utilização
Instruções de uso
Kullanım Talimatları
Указания по использованию

Οδηγίες χρήσης
Návod k použití
Návod na použitie
Instrukcja obsługi
Használati utasítások
92190993-02
Content : 92215554 REV A

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 ii of iv
en
Guarantees
Boston Scientic Corporation reserves the right to modify, without prior notice, information relating
to its products in order to improve their reliability or operating capacity.
Drawings are for illustration purposes only.
Trademarks
All trademarks are the property of their respective holders.
Additional Information
For other device-specic information not included in this manual, or labeling symbols, refer to the
appropriate DFU as listed on your DBS Reference Guide.
Registration Information
In accordance with international practice and regulatory legislation in some countries, a registration
form is packed with each Boston Scientic Stimulator, DBS Lead, and DBS Extension. The purpose
of this form is to maintain traceability of all products and to secure warranty rights. It also allows the
institution involved in the evaluation or replacement of a specic implanted DBS Lead, accessory,
or device to gain quick access to pertinent data from the manufacturer.
Fill out the registration form included in the package contents. Return one copy to the Boston
Scientic Customer Service Department, keep one copy for patient records, provide one copy to
the patient, and save one copy for the physician.
Boston Scientic
Neuromodulation Corporation
Attention: Customer Service Department
25155 Rye Canyon Loop
Valencia, CA 91355, USA

Table of Contents
Vercise™ PC Information for Prescribers
92190993-02 iii of iv
en
Table of Contents
Vercise™ PC DBS System Description ...................................... 1
Intended Use / Indications for Use.............................................. 1
Safety Information........................................................................ 2
Contraindications .................................................................................2
Warnings ........................................................................................2
Precautions ...................................................................................4
Adverse Events ..............................................................................8
External Trial Stimulator 2 (ETS 2) Maintenance....................... 11
Vercise PC Stimulator Battery..................................................... 11
Elective Replacement ...........................................................................12
End of Service ......................................................................................12
Limited Warranty - Implantable Pulse Generator
(Stimulator) ................................................................................... 13
Non-Rechargeable Stimulator...............................................................13
Limited Warranty - Leads ............................................................ 14
Limited Warranty - Externals....................................................... 15
Technical Support ....................................................................... 17

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 iv of iv
en
This page intentionally left blank.

Vercise™ PC DBS System Description
Vercise™ PC Information for Prescribers
92190993-02 1 of 459
en
Vercise™ PC DBS System Description
The Vercise PC Deep Brain Stimulation (DBS) System includes a Stimulator with DBS Leads
for unilateral or bilateral stimulation. There are also DBS Extensions that allow the DBS Leads
mounted in the skull to be extended to reach the Stimulator implanted near the clavicle. The
Vercise PC DBS System utilizes current steering across eight contacts per DBS Lead to provide
precise positioning of stimulation. The Stimulator is controlled by a hand-held Remote Control, and
can be interfaced with a Clinician’s Programmer.
The battery of the non-rechargeable stimulator will become depleted. The longevity of the
Stimulator battery depends on the following factors:
• Programmed parameters
• System impedance
• Hours per day of stimulation
• Changes to stimulation made by the patient
For additional information on estimating the longevity of the non-rechargeable battery, refer to the
appropriate programming manual as listed on your DBS Reference Guide.
Note: The Vercise PC System was not made with natural latex.
Intended Use / Indications for Use
The Vercise PC DBS System is indicated for use in the following:
• Unilateral or bilateral stimulation of the subthalamic nucleus (STN) or internal globus
pallidus (GPi) for treatment of levodopa-responsive Parkinson’s disease which is not
adequately controlled with medication.
• Unilateral or bilateral stimulation of the subthalamic nucleus (STN) or internal globus
pallidus (GPi) for treatment of intractable primary and secondary dystonia, for persons 7
years of age and older.
• Thalamic stimulation for the suppression of tremor not adequately controlled by
medications in patients diagnosed with Essential Tremor or Parkinson’s disease.
• Unilateral or bilateral stimulation of the post-commissural fornix in the treatment of
patients 65 years and older with mild probable Alzheimer’s disease, as an adjunctive
therapy for patients on a stable dose of cholinesterase inhibitor medication.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 2 of 459
en
Safety Information
Contraindications
The Boston Scientic Vercise PC DBS System, or any of its components, is contraindicated for the
following:
Diathermy. Shortwave, microwave, and/or therapeutic ultrasound diathermy. The energy
generated by diathermy can be transferred to the Vercise PC DBS System, causing tissue damage
at the contact site resulting in severe patient injury or death.
Magnetic Resonance Imaging (MRI). Patients implanted with the Vercise PC
DBS System should not be subjected to MRI. MRI exposure may result in the following:
• Dislodgement of implanted components
• Heating of the contacts, or other system components, causing permanent tissue
lesioning
• Damage to the Stimulator’s electronics
• Current induction through the DBS Leads and Vercise PC DBS System causing
unpredictable levels of stimulation
• Distortion of the diagnostic image
• Personal injury or even death
Patient Incapability. Patients who are unable to properly operate the Remote Control should
not be implanted with the Vercise PC DBS System.
Poor Surgical Risks. The Vercise PC DBS System is not recommended for patients who are
poor surgical risks.
Warnings
Unauthorized Modication. Unauthorized modication to the medical devices is prohibited.
System integrity could be compromised and harm or injury to the patient could occur if the medical
devices are subjected to unauthorized modication.
Intracranial Hemorrhage. Special precautions should be taken for patients who are prone
to hemorrhage including patients with coagulopathy, with high blood pressure, or who are using
prescribed anticoagulants. Microelectrode penetration and DBS Lead insertion can put patients
who have a likelihood of intracranial hemorrhages at greater risk.
Charge Density. High levels of stimulation may damage brain tissue. To maintain safety
limits, the software will display a message when the stimulation level would exceed the limit, and
programming of these settings will be prevented.
Patients may be granted the ability to change stimulation amplitude with the Remote Control. The
software prevents patient controlled amplitude from violating the limit.

Safety Information
Vercise™ PC Information for Prescribers
92190993-02 3 of 459
en
Diathermy. Shortwave, microwave and/or therapeutic ultrasound diathermy should not be used
on patients implanted with the Vercise PC DBS System, or any of the system components. The
Stimulator, whether it is turned on or off, may be critically damaged by the use of diathermy. The
energy generated by diathermy can be transferred to the Vercise PC DBS System, causing tissue
damage at the contact site resulting in severe injury or death.
Magnetic Resonance Imaging. Patients implanted with the Vercise PC DBS System,
or any of its components, should not be subjected to Magnetic Resonance Imaging (MRI). MRI
exposure may result in the following:
• Dislodgement of implanted components
• Heating of the contacts, or other system components, causing permanent tissue
lesioning
• Damage to the Stimulator’s electronics
• Current induction through the DBS Leads and Vercise PC DBS System components
causing unpredictable levels of stimulation
• Distortion of the diagnostic image
• Personal injury or even death
Electromagnetic Interference. Strong electromagnetic elds can potentially turn the
Stimulator off, cause temporary unpredictable changes in stimulation, or interfere with the Remote
Control communication. Patients should be counseled to avoid or exercise care around the
following:
• Theft detectors such as those used at entrances/exits of department stores, libraries, and
other public establishments. The patient should proceed with caution, ensuring to move
through the center of the detector as quickly as possible.
• Security screeners, such as those used in Airport Security or at entrances to government
buildings, including hand-held scanners. The patient should request assistance to bypass
the device. If the patient must pass through the security screener, they should move
quickly through the device staying as far from the physical device as allowable.
• Power lines or power generators.
• Electric steel furnaces and arc welders.
• Large magnetized stereo speakers.
• Strong magnets.
• Automobiles or other motorized vehicles using a LoJack system or other anti-theft
systems that can broadcast a radio frequency (RF) signal. The high energy elds
produced by these systems may interfere with the operation of the Remote Control and
its ability to control stimulation.
• Other sources of electromagnetic interference, such as RF transmitters at television or
radio broadcast stations, Amateur Radio or Citizens Band radio transceivers, or Family
Radio Service band transceivers.
DBS Extension Connector and Stimulator Placement. Implanting the DBS
Extension connector in the soft tissue of the neck may increase the chance of DBS Lead breakage.
Boston Scientic recommends placing the DBS Extension connector behind the ear such that
glasses or headgear do not interfere with the system. Boston Scientic recommends that the
Stimulator be placed subclavicularly.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 4 of 459
en
Stimulator Damage. Chemical burns may result if the Stimulator housing is ruptured or
pierced, exposing the patient’s tissue to battery chemicals. Do not implant the Stimulator if the
housing is damaged.
Suicide. Depression, suicidal ideation, and suicide are known risks of DBS. Consider adjustment
of stimulation, discontinuing stimulation, adjusting medication, and/or psychiatric referral.
Other Active Implantable Devices. Concurrent use of stimulators such as the Vercise PC
Stimulator and other active implantable devices such as pacemakers or cardioverter debrillators
may result in interference with the operations of the devices. If the patient requires concomitant
implantable active devices, careful programming of each system is necessary.
Automobiles and Equipment. Patients should operate automobiles, other motorized
vehicles, or potentially dangerous machinery/equipment with caution after receiving the Vercise PC
DBS System. Performing activities that would be dangerous if treated symptoms were to return, or
instances in which stimulation changes occur, should be avoided.
Pregnancy
It is unknown whether this device may cause complications with pregnancy and/or hurt an unborn
baby.
Precautions
Physician training is required for usage of the Vercise PC DBS System. The implanting physician
should be experienced in the subspecialty of Stereotactic and Functional Neurosurgery. The
following is a list of precautions that should be taken when implanting or using the DBS Stimulator.
Connections. Before inserting any DBS Lead or DBS Extension into any connector or header
ports, including the Stimulator header, DBS Extension connectors, and operating room cable
assembly, always wipe the DBS Lead with a sterile, dry cotton sponge. Contamination inside the
ports may be difcult to remove and can cause high impedances, preventing electrical connectivity
which may compromise the integrity of the stimulation circuit.
Components. The use of components other than those supplied by Boston Scientic and
intended for use with the Vercise PC DBS System may damage the system, diminish the
effectiveness of therapy, and/or put the patient at unknown risk.
Excess DBS Extension. Coil excess DBS Extension around or below the Stimulator. Excess
wire on top of the Stimulator may increase the potential for tissue erosion or damage during
Stimulator replacement surgery.
Other Models of External Devices. Only the Remote Control and Clinician Programmer
that were provided with the Boston Scientic Vercise PC DBS System should be used with the
Vercise PC DBS System. Other models of these devices will not function with the Vercise PC DBS
System.
Stimulator Orientation. Orient the Stimulator parallel to the skin surface. Suboptimal
placement of the Stimulator may result in a revision surgery. Patients should avoid touching the
Stimulator site or incisions. If patients notice a change in appearance of the skin at the Stimulator
location, such as the skin becoming thin over time, they should contact their physician.

Safety Information
Vercise™ PC Information for Prescribers
92190993-02 5 of 459
en
Setscrews. Before tightening Setscrews, always test impedance to conrm electrical
connectivity. Tightening a Setscrew onto a contact may damage the contact and may result in the
need to replace the DBS Lead or DBS Extension.
Sutures. Do not apply sutures tightly around the DBS Leads, as this may damage the insulation
of the DBS Lead and may result in DBS Lead failure.
Surgical Tape. If tape is used to temporarily secure the DBS Lead during surgery, caution
should be used to ensure the Lead is not cut or damaged when removing the tape.
Device Failure. Implants can fail at any time due to random component failure, loss of battery
functionality, or DBS Lead breakage. Suddenly stopping brain stimulation can cause serious
reactions to develop. If the Stimulator stops working, patients should be instructed to turn off
the Stimulator and contact their physician immediately so that the system can be evaluated and
appropriate medical care given to manage the return of symptoms.
Tissue Reaction. Temporarily, there may be some pain in the area of the Stimulator as the
incisions heal. If there is excessive redness around the wound area, it should be checked for
infection. In rare cases, adverse tissue reaction to implanted materials can occur.
Cell Phones. While interference with cell phones is not anticipated, the full effects of interaction
with cell phones are unknown at this time. Patients should be instructed to avoid placing the cell
phone directly over the Implanted Stimulator. If interference does occur, move the cell phone away
from the Implanted Stimulator or turn off the phone.
Patient Activities. During the two weeks following surgery, it is important for the patient to
exercise extreme care so that appropriate healing will secure the implanted components. During
this period, the patient should not attempt to move heavy objects. Instruct the patient to restrict
head movements, including extension or exion of the neck and rotation of the head, until healing
is complete.
Massage Therapy. Patients should avoid receiving massage therapy near the implanted
system components. If a patient does receive massage therapy, the patient should inform the
masseuse that they have an implanted device and show him/her where the Stimulator, DBS
Extension, and DBS Leads are located. The patient should have the masseuse avoid these areas
and proceed with caution.
Environmental Precautions. Patients should avoid activities that could potentially involve
large amounts of electromagnetic interference. Devices that contain permanent magnets, such as
speakers, should not be placed near the Stimulator because they may cause the system to turn on
or off.
Medical Devices/Therapies. The following medical therapies or procedures may turn
stimulation off, cause permanent damage to the Stimulator, or may cause injury to the patient:
• Electrocautery – Electrocautery can transfer destructive current into the DBS Leads and/
or Stimulator.
• External Debrillation – Safe usage of external debrillation has not been established
and damage should be ascertained following debrillation.
• Lithotripsy – High frequency signals directed near the Stimulator may damage circuitry.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 6 of 459
en
• Radiation Therapy – Lead shielding should be used over the Stimulator to prevent
damage from high radiation. Any damage to the device by radiation may not be
immediately detectable.
• Transcranial Stimulation – Safe use of electromagnetic therapies, such as transcranial
magnetic stimulation, have not been established.
• MRI – Patients implanted with the Vercise PC DBS System should not be subjected to
MRI to avoid damage to the device and patient harm.
• Diathermy – The energy generated by diathermy can be transferred to the Vercise PC
DBS System and may result of damage to the device or patient harm.
If any of the above is required by medical necessity, the procedure(s) should be performed as
far from the implanted components as possible. Ultimately, however, the Stimulator may require
explantation as a result of damage to the device or patient harm.
Sterilization. Contents of the surgical kits are supplied sterile using an ethylene oxide
process. Do not use if sterile barrier is damaged. If damage is found, call your Boston Scientic
representative and return the damaged part to Boston Scientic.
Resterilization. For single patient use only. Do not reuse, reprocess or resterilize. Reuse,
reprocessing or resterilization may compromise the structural integrity of the device and/or lead to
device failure which, in turn, may result in patient injury, illness or death. Reuse, reprocessing or
resterilization may also create a risk of contamination of the device and/or cause patient infection
or cross-infection, including, but not limited to, the transmission of infectious disease(s) from one
patient to another. Contamination of the device may lead to injury, illness or death of the patient. If
resterilization is desired, obtain a new sterile device for implantation.
After use, return the Stimulator, DBS Leads, and DBS Extensions to Boston Scientic and dispose
of other components and packaging in accordance with hospital, administrative and/or local
government policy.
Check the expiration date on the package before opening the sterile package and using the
contents. Do not use the contents if the current date is past the expiration date, if the package is
opened or damaged, or if contamination is suspected because of a defective sterile package seal.
• Inspect the seal integrity of the outer tray before use.
• Inspect the seal integrity and sterile indicator on the inner tray. The sterile indicator will
be green with red stripes if sterile. Yellow stripes indicate the tray is not sterile. If the tray
is not sterile, do not use the components and return to Boston Scientic.
• Open the inner tray in the sterile eld.
• If the Stimulator was dropped, do not implant it in a patient. The dropped Stimulator
may have lost sterility, experienced a loss of hermeticity, or been otherwise damaged.
Replace the dropped Stimulator with a new, sterile Stimulator prior to implantation.
Return the damaged Stimulator to Boston Scientic.
• Do not use any component that shows signs of damage.
• Do not use if “Use By” date has expired.
Operating Temperature. The operating temperature of the External Trial Stimulator, Remote
Control, and Programing Wand is 5–40 °C (41–104 °F).

Safety Information
Vercise™ PC Information for Prescribers
92190993-02 7 of 459
en
Storage, Handling and Transport. Store implanted components like Stimulators, Leads,
and Extensions between 0 °C to 45 °C (32 °F to 113 °F) in an area where they are not exposed
to liquids or excessive moisture. Temperatures outside of the stated range can cause damage.
If stored in conditions beyond the required storage temperature, do not use the components and
return to Boston Scientic.
The non-rechargeable Stimulator will enter storage mode if its temperature falls below 8 °C. When
the Stimulator is in storage mode, it will not connect to a Remote Control or Clinician Programmer.
To exit storage mode, increase the Stimulator temperature above 8 °C.
Store external components like the Remote Control, External Trial Stimulator, ETS Adapter, OR
Cable and Extension between -20 ° to 60 °C (-4 ° to 140 °F). Do not expose the Remote Control or
External Trial Stimulator 2 (ETS 2) to excessively hot or cold conditions. Do not leave the devices
in your car or outdoors for extended periods of time. The sensitive electronics can be damaged by
temperature extremes, particularly high heat.
Handle the system components and accessories with care. Do not drop them or submerge them
in water. Accessories, including the Remote Control, must be kept dry and not be exposed to
moisture. Although reliability testing has been performed to ensure quality manufacturing and
performance, dropping the devices on hard surfaces or in water, or other rough handling, can
permanently damage the components. Keep the Remote Control away from pets, pests, and
children to avoid damage to the device.
Care must be taken to avoid damaging the DBS Lead with sharp instruments or excessive force
during surgery. The following guidelines will help to ensure the longevity of components:
• Do not sharply bend or kink the DBS Lead or Extension.
• Do not tie suture(s) directly to the DBS Lead or Extension body.
• Avoid pulling an implanted DBS Lead taut; stress relief loops may help to minimize
tension on the DBS Lead.
• Avoid handling the DBS Lead with sharp instruments; use only rubber-tipped forceps.
• Take care when using sharp instruments, such as hemostats or scalpels, to prevent
damaging the DBS Lead.
Component Removal & Disposal. Any explanted components should be returned to
Boston Scientic. The Stimulator should be explanted in the case of cremation and returned to
Boston Scientic. Cremation may cause the Stimulator battery to explode.
The Remote Control should not be disposed of in re, as this device contains batteries which may
explode causing injury when exposed to re. Used batteries should be disposed of in accordance
with local laws and regulations.
Cleaning the Remote Control and ETS 2. The components can be cleaned using
alcohol or a mild detergent applied with a cloth or tissue. Residue from soapy detergents should
be removed with a damp cloth. Do not use abrasive cleansers for cleaning. Do not clean any of the
accessories while they are directly or indirectly connected to a power outlet.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 8 of 459
en
As an operator of the external devices, you should perform only the following service and
maintenance tasks on the external devices:
• Changing the battery
• Charging the battery
• Cleaning
Ensure that the devices are not in use while performing service and maintenance tasks.
Adverse Events
The following is a list of known risks with the use of deep brain stimulation. Specic adverse events
may be more relevant depending on the indication and site of stimulation. Not all risks are known.
Note that some of these symptoms may be resolved or reduced by current steering, changing
stimulation parameters, or by changing the position of the lead during surgery.
If any of these events occur, patients should inform their physician as soon as possible.
• Allergic or immune system response
• Anesthesia/neurosurgery risks, including unsuccessful implant, exposure to bloodborne
pathogens
• CSF leak
• Death, including suicide
• Embolism, including air embolism and pulmonary embolism
• Failure or malfunction of any of the device components or the battery, including but
not limited to lead or extension breakage, hardware malfunctions, loose connections,
electrical shorts or open circuits and lead insulation breaches, whether or not this
requires explant and/or reimplantation
• Hemorrhagic or ischemic stroke, immediate or delayed, which could result in temporary
or permanent neurologic decits such as muscle weakness, paralysis or aphasia
• Implant site complications such as pain, poor healing, wound reopening
• Infection
• Injury to tissues adjacent to implant or within surgical eld, such as blood vessels,
peripheral nerves, brain (including pneumocephalus), or pleura (including
pneumothorax).
• Interference from external electromagnetic sources
• Lead, extension (including extension header) and neurostimulator erosion or migration
• Loss of adequate stimulation
• Mentation impairment such as attention or cognitive decits, memory disturbances, or
confusion
• Psychiatric disturbances such as anxiety, depression, apathy, mania, insomnia, suicide,
or suicidal ideation or attempts
• Motor problems such as paresis, weakness, incoordination, restlessness, muscle
spasms, postural and gait disorders, tremor, dystonia, or dyskinesias, and falls or injuries
resulting from these problems

Safety Information
Vercise™ PC Information for Prescribers
92190993-02 9 of 459
en
• Musculoskeletal stiffness
• Neuroleptic malignant syndrome or acute akinesia can occur very rarely
• Overstimulation or undesirable sensations, such as paresthesia, transient or persistent
• Pain, headache or discomfort, transient or persistent, including symptoms due to
neurostimulation
• Poor initial lead location
• Radiation exposure due to imaging (CT, uoroscopy x-ray)
• Seizures
• Sensory changes
• Seroma, edema or hematoma
• Skin irritation or burns at neurostimulator site
• Speech or swallowing problems such as dysphasia, dysarthria or dysphagia, as well as
complications of dysphagia such as aspiration pneumonia
• Systemic symptoms-autonomic (tachycardia, sweating, increased blood pressure,
ushing, fever, dizziness), changes in renal function, urinary retention, sexual effects,
gastrointestinal (nausea, bowel retention, bloating)
• Thrombosis
• Undesirable sensations such as tingling or generalized warming
• Visual disturbances or periorbital symptoms, such as diplopia, eyelid movement difculty,
oculomotor difculties, transient ashes of light or other visual eld effects
• Vivid memories
• Weight changes
BS EN 60601-1-2 Classication Information
Testing to demonstrate compliance of the Vercise PC DBS System with the essential requirements
and other relevant provisions of Directive 1999/5/EC were leveraged from testing performed on the
Precision™ SCS System.
• Internally powered
• Continuous operation
• Ordinary equipment
• Class II

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 10 of 459
en
Table 1: Guidance and manufacturer’s declaration – electromagnetic emissions
The Vercise PC System is intended for use in electromagnetic environment specied below.
The customer or the user of the Vercise PC System should assure that it is used in such an
environment.
Emissions Test Compliance Electromagnetic environment –
guidance
RF emissions
CISPR 11
Group 1 The Vercise PC System uses RF energy
only for its internal function. Therefore, its RF
emissions are very low and are not likely to
cause any interference in nearby electronic
equipment.
RF emissions
CISPR 11
Class B The Vercise PC System is suitable for use
in all establishments, including domestic
establishments and those directly connected
to the public low voltage power supply
network that supplies buildings used for
domestic purposes.
Harmonic emissions
IEC 61000-3-2
Not Applicable
Voltage uctuations/
icker emissions
IEC 61000-3-3
Not Applicable
Hereby, Boston Scientic declares that the Vercise PC System is in compliance with the essential
requirements and other relevant provisions of Directive 1999/5/EC.
Essential Performance
Failure of the external electrical components will not result in an unacceptable risk to the user.
Telemetry Information
The following parameters describe the wireless communication link between the Stimulator and the
Remote Control:
• Frequency Band: 119 – 131 kHz
• Modulation type: FSK
• Effective Radiated Power: 0.05 mW (-13 dBm) maximum
• Magnetic Field Strength (at 3 m distance): 46 μA/m

External Trial Stimulator 2 (ETS 2) Maintenance
Vercise™ PC Information for Prescribers
92190993-02 11 of 459
en
External Trial Stimulator 2 (ETS 2) Maintenance
The ETS 2 is used to conduct intraoperative stimulation testing during the lead implantation
procedure. Refer to the DFU listed on your DBS Reference Guide for detailed procedure and
guidelines for intraoperative testing.
Figure 1: External Trial Stimulator 2
To turn stimulation on and off on the ETS, press the ON/OFF button on the ETS 2 (Figure 1). When
the stimulation is on, the Stim Indicator Light will blink green. The ETS 2 runs on two AA batteries
that are provided with every ETS 2 kit. When the batteries need replacement, the Battery Indicator
Light will change from a ashing green to a ashing yellow.
Be sure that stimulation is off (the indicator light is not blinking) before opening the Trial
Stimulator’s battery compartment.
To install new batteries:
1. Conrm that stimulation is OFF by conrming that the stimulation indicator light is not blinking.
2. On the rear of the ETS 2, push in slightly and slide down the battery compartment cover.
3. Remove the old batteries.
4. Place two new AA batteries in the slots matching the positive (+) and negative (-) markings in
the compartment.
5. Align the battery compartment cover on the case and slide the cover into position until is snaps
closed.
6. Both the Battery Indicator light and the Stim On indicator lights will emit an amber glow for 15
seconds after which the Battery indicator light blinks green.
Vercise PC Stimulator Battery
The Vercise PC Stimulator has a non-rechargeable battery. The longevity of the Stimulator battery
depends on the following factors:
• Programmed parameters
• System impedance
• Hours per day of stimulation
• Changes to stimulation made by the patient.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 12 of 459
en
For additional information on estimating the longevity of the non-rechargeable battery, refer to the
appropriate programming manual as listed on your DBS Reference Guide.
Elective Replacement
When the implanted non-rechargeable Stimulator is nearing end of its battery life, the Stimulator
will enter the Elective Replacement mode. The Elective Replacement Indicator (ERI) will appear on
the Remote Control and Clinician Programmer. Changes made to the stimulation will not be saved,
and stimulation will not be available soon. Patients should be advised to contact their physician
to report this message screen. The Stimulator must be replaced to continue receiving stimulation.
Batteries that have lasted 12 months or more without entering ERI mode will have a minimum of 4
weeks between entering ERI mode and reaching End of Battery Life. Surgery is required to replace
the implanted Non-Rechargeable Stimulator, although leads may stay in place while the Stimulator
is exchanged.
End of Service
End of Battery Life
When the Stimulator battery is fully depleted, the End of Service (EOS) indicator will be displayed
on the Remote Control and Clinician Programmer. Stimulation will not be available. Surgery is
required to replace the implanted non-rechargeable stimulator to continue providing stimulation.
End of Programmed Service
The Vercise PC Stimulator software has been programmed to end service after a dened period.
When the Stimulator is within approximately 180 days of the end of its programmed period, the
Remote Control and Clinician Programmer will display a message indicating the number of service
days available.
Refer to the programming Manual and the Remote Control DFU listed on your DBS Reference
Guide for description of the End of Service messages displayed.

Limited Warranty - Implantable Pulse Generator (Stimulator)
Vercise™ PC Information for Prescribers
92190993-02 13 of 459
en
Limited Warranty - Implantable Pulse Generator
(Stimulator)
Non-Rechargeable Stimulator
Boston Scientic Corporation warrants to the patient who receives an implantable non-
rechargeable pulse generator (referred to as the Non-Rechargeable Stimulator) that the Non-
Rechargeable Stimulator will be free from defects in workmanship and materials for a period of
two (2) years from the date of surgical implant of the Non-Rechargeable Stimulator. This warranty
applies only to the patient who has the Non-Rechargeable Stimulator implanted and no other
person or entity. This warranty does not apply to the leads, extensions, or surgical accessories
used with the Non-Rechargeable Stimulator.
A Non-Rechargeable Stimulator that fails to function within normal ranges within two (2) years after
the date it is implanted is covered under this Limited Warranty. The liability of Boston Scientic
under this warranty shall be limited to: (a) replacement of the Non-Rechargeable Stimulator with
a functionally equivalent Non-Rechargeable Stimulator made by Boston Scientic; or (b) credit
applied towards the purchase of a new Stimulator. The warranty amount is calculated using least
expensive device price (original vs. replacement). No other relief whatsoever is available under
this limited warranty. This limited warranty for a replacement Non-Rechargeable Stimulator will last
only for two years from the date of surgical implant of the original Non-Rechargeable Stimulator.
Note: Battery life of a Non-rechargeable Stimulator may vary due to a variety of factors.
Therefore, this warranty shall not extend to battery depletion of a Non-rechargeable
Stimulator unless such depletion is caused by a defect in workmanship or material.
Claims under this limited warranty are subject to the following additional conditions and limitations:
1. The product registration card must be completed and returned to Boston Scientic within 30
days of surgery.
2. The Non-Rechargeable Stimulator must be implanted before the “Use By” date.
3. Failure of the Non-Rechargeable Stimulator must be conrmed by Boston Scientic.
4. The Non-Rechargeable Stimulator must be returned to Boston Scientic (or a Boston Scientic
authorized agent) within 30 days after it fails to function within normal ranges. That Non-
Rechargeable Stimulator will be the property of Boston Scientic.
5. The limited warranty does not include failures to function within normal ranges caused by:
(a). Fire, oods, lightning, natural disasters, water damage, and other calamities commonly
dened as “Acts of God”;
(b). Accident, misuse, abuse, negligence, or the customer’s failure to operate the Non-
Rechargeable Stimulator in accordance with manufacturer’s instructions;
(c). Unauthorized attempts to repair, maintain, or modify the Non-Rechargeable Stimulator for
the patient or any unauthorized third party; or
(d). Attaching equipment to the Non-Rechargeable Stimulator that is not supplied or expressly
authorized by Boston Scientic.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 14 of 459
en
This limited warranty is the only warranty that applies to the Non-Rechargeable Stimulator, and
Boston Scientic expressly disclaims any other warranty, express or implied, including any warranty
of merchantability or tness for a particular purpose. Under this limited warranty, Boston Scientic
will be responsible only for replacement of the Non-Rechargeable Stimulator with a functionally
equivalent Non-Rechargeable Stimulator made by Boston Scientic and will not be liable for any
damages (whether direct, indirect, consequential,or incidental) caused by the Non-Rechargeable
Stimulator, whether the claim is based on warranty, contract, tort or any other theory.
Boston Scientic assumes no liability with respect to instruments reused, reprocessed
or resterilized and makes no warranties, express or implied, including but not limited to
merchantability or tness for a particular purpose, with respect to such instruments.
Limited Warranty - Leads
Boston Scientic Corporation (referred to as Boston Scientic) warrants to the patient that the DBS
Leads, Lead Extensions, and Lead Boots are free from defects in workmanship and materials for a
period of one (1) year from the date of implantation.
A Lead, Extension, or Boot that fails to function within normal tolerances within (1) year from the
date of surgery is covered under this Limited Warranty. The liability of Boston Scientic under this
warranty shall be limited to: (a) replacement with a functionally equivalent Lead, Extension, or Boot;
or (b) full credit equal to the original purchase price to be applied towards the purchase of a new
Lead, Extension, or Boot. Product claims under Boston Scientic Limited Warranty are subject to
the following conditions and limitations:
1. The product registration card must be completed and returned to Boston Scientic within 30
days of surgery in order to obtain warranty rights.
2. The Lead, Extension, or Boot must be returned to Boston Scientic (or authorized agent) within
30 days of malfunction or discovery of defect, and shall be the property of Boston Scientic.
3. The Lead, Extension, or Boot must be implanted prior to the “use by” date.
4. Failure of the Lead, Extension, or Boot must be conrmed by Boston Scientic. This warranty
specically excludes defects or malfunctions caused by: (a) re, oods, lightning, natural
disasters, water damage, and other calamities commonly dened as “Acts of God”; (b)
accident, misuse, abuse, negligence, or the customer’s failure to operate the Lead, Extension,
and Boot in accordance with manufacturer’s instructions; (c) unauthorized attempts to repair,
maintain, or modify the equipment by the customer or any unauthorized third party; or (d)
attachment of any equipment not supplied by Boston Scientic without prior approval.
(a). This warranty does not include surgical accessories used with the Lead, Extension, or
Boot.
5. The decision as to product replacement or credit shall be made solely at the discretion of
Boston Scientic. For a replacement Lead, Extension, or Boot, the warranty will run only to the
end of the warranty period for the original Lead, Extension, or Boot that was replaced.
This warranty is in lieu of any other warranty, expressed or implied, including any warranty
of merchantability or tness for intended use. Except as expressly provided by this Limited
Warranty, Boston Scientic shall not be responsible or liable for any direct, consequential
or incidental damages caused by device malfunction, failure or defect, whether the claim is
based on warranty, contract, tort, or otherwise.

Limited Warranty - Externals
Vercise™ PC Information for Prescribers
92190993-02 15 of 459
en
Boston Scientic assumes no liability with respect to instruments reused, reprocessed
or resterilized and makes no warranties, express or implied, including but not limited to
merchantability or tness for a particular purpose, with respect to such instruments.
Limited Warranty - Externals
Boston Scientic Corporation (referred to as Boston Scientic) warrants to the patient that the
Remote Control device and Charging System (Charger and/or Charger Base Station) are free from
defects in workmanship and materials for a period of one (1) year from the date of purchase.
If a Remote Control Device or Charging System component fails to function within normal ranges
within one year after the date of purchase, Boston Scientic will replace the device or component
with a functionally equivalent device or component made by Boston Scientic. No other relief
whatsoever is available under this limited warranty. The limited warranty for a replacement device
or component will last only for one year after the date of purchase. Claims under this limited
warranty are subject to the following additional conditions and limitations:
1. The product registration card must be completed and returned to Boston Scientic within 30
days of purchase.
2. Boston Scientic must conrm the device or component failure.
3. The device or component must be returned to Boston Scientic (or Boston Scientic’s
authorized agent) within 30 days after it fails to function within normal ranges. That device or
component will be Boston Scientic’s property.
4. This limited warranty does not include failures to function within normal ranges caused by:
(a). re, oods, lightning, natural disasters, water damage, and other calamities commonly
dened as “Acts of God”;
(b). accident, misuse, abuse, negligence, or the customer’s failure to operate the device or
component in accordance with manufacturer’s instructions;
(c). unauthorized attempts to repair, maintain, or modify the device or component by the
patient or any unauthorized third party; or
(d). attaching equipment to the device or component that is not supplied or expressly
authorized by Boston Scientic.
This limited warranty is the only warranty that applies to the device or component, and
Boston Scientic expressly disclaims any other warranty, express or implied, including any
warranty of merchantability or tness for a particular purpose.

Vercise™ PC Information for Prescribers
Vercise™ PC Information for Prescribers
92190993-02 16 of 459
en
Under this limited warranty, Boston Scientic will be responsible only for replacement of the device
or component with a functionally equivalent device or component made by Boston Scientic and
will not be liable for any damages (whether direct, indirect, consequential, or incidental) caused
by the device or component, whether the claim is based on warranty, contract, tort, or any other
theory.
The following is federal government communications regulation information about the Vercise PC
DBS System.
This device complies with part 15 of the FCC Rules. Operation is subject to the following two
conditions: (1) This device may not cause harmful interference, and (2) This device must accept
any interference received including interference that may cause undesired operation.